Anti-apoptotic effects of caspase inhibitors on rat intervertebral disc cells

Journal of Bone and Joint Surgery

Volumn 88, Issue 4, 2006, Pages 771-779

  Park, Jong Beom ^a   Park, In Chul ^a   Park, Sung Jin ^b   Jin, Hyeon Ok ^b   Lee, Jin Kyung ^b   Riew, K Daniel ^c  

^a Uijeongbu St Mary's Hospital   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CASPASE; CASPASE 3; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE 9 INHIBITOR; CASPASE INHIBITOR; CYTOCHROME C; FAS ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROPIDIUM IODIDE; STAUROSPORINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL FRACTIONATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DEATH INDUCING SIGNALING COMPLEX; ENZYME ACTIVITY; FLOW CYTOMETRY; INTERVERTEBRAL DISK; MITOCHONDRIAL MEMBRANE; NONHUMAN; NUCLEUS PULPOSUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; WESTERN BLOTTING;

EID: 33645657253     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.E.00762     Document Type: Article

References (25)

1. Guttenplan N, Lee C, Frishman WH. Inhibition of myocardial apoptosis as a therapeutic target in cardiovascular disease prevention: focus on caspase inhibition. Heart Dis. 2001;3:313-8.
2. Kreuter M, Langer C, Kerkhoff C, Reddanna P, Kania AL, Maddika S, Chlichlia K, Bui TN, Los M. Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development. Arch Immunol Ther Exp (Warsz). 2004;52:141-55.
3. Gruber HE, Hanley EN Jr. Analysis of aging and degeneration of the human intervertebral disc. Comparison of surgical specimens with normal controls. Spine. 1998;23:751-7.
4. Creagh EM, Conroy H, Martin SJ. Caspase-activation pathways in apoptosis and immunity. Immunol Rev. 2003;193:10-21.
5. Krammer PH. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol. 1999;71:163-210.
6. Concha NO, Abdel-Meguid SS. Controlling apoptosis by inhibition of caspases. Curr Med Chem. 2002;9:713-26.
7. Philchenkov A. Caspases: potential targets for regulating cell death. J Cell Mol Med. 2004;8:432-44.
8. Cheng Y, Deshmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A, Sun Y, Jacquin MF, Johnson EM, Holtzman DM. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest. 1998;101:1992-9.
9. Kunstle G, Leist M, Uhlig S, Revesz L, Feifel R, MacKenzie A, Wendel A. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or TNF-alpha. Immunol Lett. 1997;55:5-10.
10. Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P. Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med. 2001;163:218-25.
11. Rouquet N, Pages JC, Molina T, Briand P, Joulin V. Ice inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol. 1996;6:1192-5.
12. Yang B, Johnson TS, Haylor JL, Wagner B, Watson PF, El Kossi MM, Furness PN, El Nahas AM. Effects of caspase inhibition on the progression of experimental glomerulonephritis. Kidney Int. 2003;63:2050-64.
13. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 1998;97:276-81.
14. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998;17:1675-87.
15. Park JB, Kim KW, Han CW, Chang H. Expression of Fas receptor on disc cells in herniated lumbar disc tissue. Spine. 2001;26:142-5.
16. Park JB, Chang H, Kim KW. Expression of Fas ligand and apoptosis of disc cells in herniated lumbar disc tissue. Spine. 2001;26:618-21.
17. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME. Differential modulation of apoptosis sensitivity in CD95 type I and II cells. J Biol Chem. 1999;274:22532-8.
18. Park JB, Lee JK, Park SJ, Kim KW, Riew KD. Mitochondrial involvement in fas-mediated apoptosis of human lumbar disc cells. J Bone Joint Surg Am. 2005;87:1338-42.
19. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84:1415-20.
20. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods. 1995;184:39-51.
21. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132-6.
22. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147-57.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
24. Rannou F, Lee TS, Zhou RH, Chin J, Lotz JC, Mayoux-Benhamou MA, Barbet JP, Chevrot A, Shyy JY. Intervertebral disc degeneration: the role of the mitochondrial pathway in annulus fibrosus cell apoptosis induced by overload. Am J Pathol. 2004;164:915-24.
25. Ekert PG, Silke J, Vaux DL. Caspase inhibitors. Cell Death Differ. 1999;6:1081-6.